Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation
Key Points
Examine malpractice claims related to pancreatic cancer, focusing on claim rates and outcomes.
Analyzed claim data over a specified period
Identified causes of claims
Assessed approval rates and compensation amounts
Claim rate remained stable at 1.5%
One in five claims were approved
Diagnostic delay was the primary reason for claims
Abstract
The claim rate of 1.5% was stable, with about one in five claims approved. Diagnostic delay was the predominant cause, with several stakeholders involved across the healthcare system.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation | Synapse